Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice

Systemic lupus erythematosus (SLE) is a debilitating multi-factorial immunological disorder characterized by increased inflammation and development of anti-nuclear autoantibodies. Selenium (Se) is an essential trace element with beneficial anti-cancer and anti-inflammatory immunological functions. I...

Full description

Bibliographic Details
Main Authors: Chetna Soni, Indu Sinha, Melinda J. Fasnacht, Nancy J. Olsen, Ziaur S.M. Rahman, Raghu Sinha
Format: Article
Language:English
Published: Taylor & Francis Group 2019-02-01
Series:Autoimmunity
Subjects:
Online Access:http://dx.doi.org/10.1080/08916934.2019.1603297
_version_ 1797684740212391936
author Chetna Soni
Indu Sinha
Melinda J. Fasnacht
Nancy J. Olsen
Ziaur S.M. Rahman
Raghu Sinha
author_facet Chetna Soni
Indu Sinha
Melinda J. Fasnacht
Nancy J. Olsen
Ziaur S.M. Rahman
Raghu Sinha
author_sort Chetna Soni
collection DOAJ
description Systemic lupus erythematosus (SLE) is a debilitating multi-factorial immunological disorder characterized by increased inflammation and development of anti-nuclear autoantibodies. Selenium (Se) is an essential trace element with beneficial anti-cancer and anti-inflammatory immunological functions. In our previous proteomics study, analysis of Se-responsive markers in the circulation of Se-supplemented healthy men showed a significant increase in complement proteins. Additionally, Se supplementation prolonged the life span of lupus prone NZB/NZW-F1 mice. To better understand the protective immunological role of Se in SLE pathogenesis, we have investigated the impact of Se on B cells and macrophages using in vitro Se supplementation assays and the B6.Sle1b mouse model of lupus with an oral Se or placebo supplementation regimen. Analysis of Se-treated B6.Sle1b mice showed reduced splenomegaly and splenic cellularity compared to untreated B6. Sle1b mice. A significant reduction in total B cells and notably germinal center (GC) B cell numbers was observed. However, other cell types including T cells, Tregs, DCs and pDCs were unaffected. Consistent with reduced GC B cells there was a significant reduction in autoantibodies to dsDNA and SmRNP of the IgG2b and IgG2c subclass upon Se supplementation. We found that increased Se availability leads to impaired differentiation and maturation of macrophages from mouse bone marrow derived progenitors in vitro. Additionally, Se treatment during in vitro activation of B cells with anti-CD40L and LPS inhibited optimal B cell activation. Overall our data indicate that Se supplementation inhibits activation, differentiation and maturation of B cells and macrophages. Its specific inhibitory effect on B cell activation and GC B cell differentiation could be explored as a potential therapeutic supplement for SLE patients.
first_indexed 2024-03-12T00:34:11Z
format Article
id doaj.art-754cca12b3b0417289742e6b20eacc2c
institution Directory Open Access Journal
issn 0891-6934
1607-842X
language English
last_indexed 2024-03-12T00:34:11Z
publishDate 2019-02-01
publisher Taylor & Francis Group
record_format Article
series Autoimmunity
spelling doaj.art-754cca12b3b0417289742e6b20eacc2c2023-09-15T10:01:08ZengTaylor & Francis GroupAutoimmunity0891-69341607-842X2019-02-01522576810.1080/08916934.2019.16032971603297Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b miceChetna Soni0Indu Sinha1Melinda J. Fasnacht2Nancy J. Olsen3Ziaur S.M. Rahman4Raghu Sinha5Pennsylvania State University College of MedicinePennsylvania State University College of MedicinePennsylvania State University College of MedicinePennsylvania State University College of MedicinePennsylvania State University College of MedicinePennsylvania State University College of MedicineSystemic lupus erythematosus (SLE) is a debilitating multi-factorial immunological disorder characterized by increased inflammation and development of anti-nuclear autoantibodies. Selenium (Se) is an essential trace element with beneficial anti-cancer and anti-inflammatory immunological functions. In our previous proteomics study, analysis of Se-responsive markers in the circulation of Se-supplemented healthy men showed a significant increase in complement proteins. Additionally, Se supplementation prolonged the life span of lupus prone NZB/NZW-F1 mice. To better understand the protective immunological role of Se in SLE pathogenesis, we have investigated the impact of Se on B cells and macrophages using in vitro Se supplementation assays and the B6.Sle1b mouse model of lupus with an oral Se or placebo supplementation regimen. Analysis of Se-treated B6.Sle1b mice showed reduced splenomegaly and splenic cellularity compared to untreated B6. Sle1b mice. A significant reduction in total B cells and notably germinal center (GC) B cell numbers was observed. However, other cell types including T cells, Tregs, DCs and pDCs were unaffected. Consistent with reduced GC B cells there was a significant reduction in autoantibodies to dsDNA and SmRNP of the IgG2b and IgG2c subclass upon Se supplementation. We found that increased Se availability leads to impaired differentiation and maturation of macrophages from mouse bone marrow derived progenitors in vitro. Additionally, Se treatment during in vitro activation of B cells with anti-CD40L and LPS inhibited optimal B cell activation. Overall our data indicate that Se supplementation inhibits activation, differentiation and maturation of B cells and macrophages. Its specific inhibitory effect on B cell activation and GC B cell differentiation could be explored as a potential therapeutic supplement for SLE patients.http://dx.doi.org/10.1080/08916934.2019.1603297b cellsgerminal centermacrophagesseleniumsystemic lupus erythematosus
spellingShingle Chetna Soni
Indu Sinha
Melinda J. Fasnacht
Nancy J. Olsen
Ziaur S.M. Rahman
Raghu Sinha
Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice
Autoimmunity
b cells
germinal center
macrophages
selenium
systemic lupus erythematosus
title Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice
title_full Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice
title_fullStr Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice
title_full_unstemmed Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice
title_short Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice
title_sort selenium supplementation suppresses immunological and serological features of lupus in b6 sle1b mice
topic b cells
germinal center
macrophages
selenium
systemic lupus erythematosus
url http://dx.doi.org/10.1080/08916934.2019.1603297
work_keys_str_mv AT chetnasoni seleniumsupplementationsuppressesimmunologicalandserologicalfeaturesoflupusinb6sle1bmice
AT indusinha seleniumsupplementationsuppressesimmunologicalandserologicalfeaturesoflupusinb6sle1bmice
AT melindajfasnacht seleniumsupplementationsuppressesimmunologicalandserologicalfeaturesoflupusinb6sle1bmice
AT nancyjolsen seleniumsupplementationsuppressesimmunologicalandserologicalfeaturesoflupusinb6sle1bmice
AT ziaursmrahman seleniumsupplementationsuppressesimmunologicalandserologicalfeaturesoflupusinb6sle1bmice
AT raghusinha seleniumsupplementationsuppressesimmunologicalandserologicalfeaturesoflupusinb6sle1bmice